Business EconomyPosted at: Nov 12 2025 12:41AM


Granules Life Sciences gets first U.S. FDA approval for Hyderabad Facility

Hyderabad, Nov 11 (UNI) Granules India Limited, on Tuesday announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), located here, has received U.S. Food and Drug Administration (FDA) approval for a product that was the subject of a Pre-Approval Inspection (PAI) conducted between July 28 and August 1.
There was one observation during that inspection, and the GLS had submitted its response within the stipulated time.
With this approval, the GLS facility is now deemed approved by the U.S. FDA, marking a major milestone for Granules India as it expands its finished dosage manufacturing capabilities. This is the first FDA approval for the GLS site, the Hyderabad pharma said in a release here.
The company plans to launch the approved product in the U.S. market soon. The same product is already approved and manufactured at Granules’ Gagillapur facility. The new approval will help strengthen market share and support business continuity through multi-site manufacturing.
“We plan on launching the product into the U.S. market soon. It is an already approved product at our Gagillapur facility, but we plan on building market share with this approval,” said Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited.
“We also have other products filed from this site and expect the U.S. FDA to approve them following necessary audits if required. This marks the first approval from our second Hyderabad facility with finished dosage capabilities,” he added.
UNI KNR SSP
Please log in to get detailed story.
Tags: #Granules Life Sciences gets first U.S. FDA approval for Hyderabad Facility
More News

Chola MS named ‘Insurer of the year at FICCI Awards

15 Dec 2025 | 6:00 PM

Chennai, Dec 15 (UNI) Chola MS General Insurance, a joint venture between the Murugappa Group and Mitsui Sumitomo Insurance Company Limited, Japan, has been conferred the ‘Insurer of the Year – Best Operating Performance (Non-Life Category)’ at the FICCI Insurance Industry Awards 2024.

see more..

Galaxy Health launches comprehensive product, working on travel insurance policy

15 Dec 2025 | 4:27 PM

Chennai, Dec 15 (UNI) With the focus on catching them young, city based health insurer Galaxy Health Insurance Company Ltd on Monday launched its new comprehensive health insurance policy for those in 18-45 years age bracket, said a top company official.

see more..

Rising cost of education & superior returns boost investors interest in children’s mutual funds: ICRA Analytics

15 Dec 2025 | 3:51 PM

Kolkata, Dec 15 (UNI) Children’s mutual fund, which has clocked an impressive CAGR growth of around 21.08 per cent over the last five years, is expected to register a double-digit growth in the coming years. Rising cost of education, which has been increasing by 11–12 per cent annually, and the superior returns generated by these funds are driving parents toward market-linked instruments for long-term planning, ICRA Analytics said.

see more..

Wheels India signs technical agreement with Japan’s Topy industries

15 Dec 2025 | 1:48 PM

Chennai, Dec 15 (UNI) Wheels India has signed a Technical Assistance Agreement with Tokyo,
Japan headquartered Topy Industries for the design, development and manufacture of aluminium alloy
wheels.

see more..

KPMG report says EV sales in India could reach 22 million units by 2035

15 Dec 2025 | 1:41 PM

Kolkata, Dec 15 (UNI) India’s electric vehicle (EV) journey has evolved from cautious early adoption to rapid acceleration, driven by strong government support, favorable economics, rapid infrastructure development, technological progress, and changing consumer preferences.

see more..